|
Television Viewing Time and Mortality. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). DW Dunstan,EL Barr,GN Healy,J Salmon,JE Shaw,B Balkau,DJ Magliano,AJ Cameron,PZ Zimmet,N Owen Circulation 2010 1;():
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. DM Reid,JP Devogelaer,K Saag,C Roux,CS Lau,JY Reginster,P Papanastasiou,A Ferreira,F Hartl,T Fashola,P Mesenbrink,PN Sambrook Lancet 2009 4;373(9671):1253-63
Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety. EC Walvoord,A de la Peña,S Park,B Silverman,L Cuttler,SR Rose,G Cutler,S Drop,JJ Chipman J Clin Endocrinol Metab 2009 6;94(6):2052-9
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. M Debono,RJ Ross,J Newell-Price Eur J Endocrinol 2009 5;160(5):719-29
Impact of aromatase inhibitor therapy on bone turnover, cortical bone growth and vertebral morphology in pre- and peripubertal boys with idiopathic short stature. M Hero,O Mäkitie,H Kröger,E Nousiainen,S Toiviainen-Salo,L Dunkel Horm Res 2009 1;71(5):290-7
Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. RF de Lind van Wijngaarden,LW de Klerk,DA Festen,HJ Duivenvoorden,BJ Otten,AC Hokken-Koelega J Clin Endocrinol Metab 2009 4;94(4):1274-80
Insulin sensitivity decreases in short children born small for gestational age treated with growth hormone. S Bachmann,S Bechtold,W Bonfig,S Putzker,M Buckl,HP Schwarz J Pediatr 2009 4;154(4):509-13
|